Production of Biopolymeric Microparticles to Improve Cannabigerol Bioavailability
Abstract
:1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Methods
2.2.1. SAA Lab-Scale Plant
2.2.2. Preparation of CBG–PVP Solution
2.2.3. Characterizations
3. Results and Discussion
3.1. Effect of the CBG/PVP Mass Ratio
3.2. Effect of the Total Solute Concentration
3.3. CBG Dissolution Tests
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Valizadehderakhshan, M.; Shahbazi, A.; Kazem-Rostami, M.; Todd, M.S.; Bhowmik, A.; Wang, L. Extraction of cannabinoids from Cannabis sativa L.(Hemp). Agriculture 2021, 11, 384. [Google Scholar] [CrossRef]
- Mandolino, G.; Bagatta, M.; Carboni, A.; Ranalli, P.; De Meijer, E. Qualitative and quantitative aspects of the inheritance of chemical phenotype in Cannabis. J. Ind. Hemp 2003, 8, 51–72. [Google Scholar] [CrossRef]
- Nachnani, R.; Raup-Konsavage, W.M.; Vrana, K.E. The pharmacological case for cannabigerol. J. Pharmacol. Exp. Ther. 2021, 376, 204–212. [Google Scholar] [CrossRef]
- De Meijer, E.P.M.; Hammond, K.M. The inheritance of chemical phenotype in Cannabis sativa L.(II): Cannabigerol predominant plants. Euphytica 2005, 145, 189–198. [Google Scholar] [CrossRef]
- Perez, E.; Fernandez, J.R.; Fitzgerald, C.; Rouzard, K.; Tamura, M.; Savile, C. In vitro and clinical evaluation of cannabigerol (CBG) produced via yeast biosynthesis: A cannabinoid with a broad range of anti-inflammatory and skin health-boosting properties. Molecules 2022, 27, 491. [Google Scholar] [CrossRef]
- Hanuš, L.O.; Meyer, S.M.; Muñoz, E.; Taglialatela-Scafati, O.; Appendino, G. Phytocannabinoids: A unified critical inventory. Nat. Prod. Rep. 2016, 33, 1357–1392. [Google Scholar] [CrossRef]
- Calapai, F.; Cardia, L.; Esposito, E.; Ammendolia, I.; Mondello, C.; Lo Giudice, R.; Gangemi, S.; Calapi, G.; Mannucci, C. Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives. Evid. Based Complement. Alternat. Med. 2022, 2022, 3336516. [Google Scholar] [CrossRef] [PubMed]
- Jastrząb, A.; Jarocka-Karpowicz, I.; Skrzydlewska, E. The origin and biomedical relevance of cannabigerol. Int. J. Mol. Sci. 2022, 23, 7929. [Google Scholar] [CrossRef] [PubMed]
- Anokwuru, C.P.; Makolo, F.L.; Sandasi, M.; Tankeu, S.Y.; Elisha, I.L.; Agoni, C.; Combrinck, S.; Viljoen, A. Cannabigerol: A bibliometric overview and review of research on an important phytocannabinoid. Phytochem. Rev. 2022, 21, 1523–1547. [Google Scholar] [CrossRef]
- Cabrera, C.L.R.; Keir-Rudman, S.; Horniman, N.; Clarkson, N.; Page, C. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulm. Pharmacol. Ther. 2021, 69, 102047. [Google Scholar] [CrossRef]
- Deiana, S. Potential medical uses of cannabigerol: A brief overview. In Handbook of Cannabis and Related Pathologies, 1st ed.; Preedy, V.R., Ed.; Elsevier/Academic Press: London, UK, 2017; pp. 958–967. [Google Scholar] [CrossRef]
- Gallicchio, S. Optimization of the Supercritical Fluid Extraction for the Recovery of Cannabigerol from Cannabis. Master’s Thesis, Department of Industrial Engineering, University of Salerno, Fisciano, Italy, 2024. [Google Scholar]
- Kogan, N.M.; Lavi, Y.; Topping, L.M.; Williams, R.O.; McCann, F.E.; Yekhtin, Z.; Feldmann, M.; Gallily, R.; Mechoulam, R. Novel CBG derivatives can reduce inflammation, pain and obesity. Molecules 2021, 26, 5601. [Google Scholar] [CrossRef] [PubMed]
- Mnekin, L.; Ripoll, L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021, 8, 85. [Google Scholar] [CrossRef]
- Gaweł-Bęben, K.; Czech, K.; Luca, S.V. Cannabidiol and minor phytocannabinoids: A preliminary study to assess their anti-melanoma, anti-melanogenic, and anti-tyrosinase properties. Pharmaceuticals 2023, 16, 648. [Google Scholar] [CrossRef]
- Luz-Veiga, M.; Amorim, M.; Pinto-Ribeiro, I.; Oliveira, A.L.; Silva, S.; Pimentel, L.L.; Rodríguez-Alcalá, L.M.; Madureira, R.; Pintado, M.; Azevedo-Silva, J.; et al. Cannabidiol and cannabigerol exert antimicrobial activity without compromising skin microbiota. Int. J. Mol. Sci. 2023, 24, 2389. [Google Scholar] [CrossRef]
- Monou, P.K.; Mamaligka, A.M.; Tzimtzimis, E.K.; Tzetzis, D.; Vergkizi-Nikolakaki, S.; Vizirianakis, I.S.; Andriotis, E.G.; Eleftheriadis, G.K.; Fatouros, D.G. Fabrication and preliminary in vitro evaluation of 3D-printed alginate films with cannabidiol (CBD) and cannabigerol (CBG) nanoparticles for potential wound-healing applications. Pharmaceutics 2022, 14, 1637. [Google Scholar] [CrossRef]
- Grotenhermen, F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 2003, 42, 327–360. [Google Scholar] [CrossRef]
- da Silva, F.C.; da Fonseca, C.R.; de Alencar, S.M.; Thomazini, M.; De Carvalho Balieiro, J.C.; Pittia, P.; Favaro-Trindade, C.S. Assessment of production efficiency, physicochemical properties and storage stability of spray-dried propolis, a natural food additive, using gum Arabic and OSA starch-based carrier systems. Food Bioprod. Process. 2013, 91, 28–36. [Google Scholar] [CrossRef]
- de Souza Ferreira, S.B.; de Assis Dias, B.R.; Obregón, C.S.; Gomes, C.C.; de Araújo Pereira, R.R.; Ribeiro Godoy, J.S.; Svidzinski, T.I.E.; Bruschi, M.L. Microparticles containing propolis and metronidazole: In vitro characterization, release study and antimicrobial activity against periodontal pathogens. Pharm. Dev. Technol. 2014, 19, 173–180. [Google Scholar] [CrossRef]
- Sahlan, M.; Supardi, T. Encapsulation of Indonesian propolis by casein micelle. Int. J. Pharma Bio Sci. 2013, 4, 297–305. [Google Scholar]
- Do Nascimento, T.G.; Da Silva, P.F.; Azevedo, L.F.; Da Rocha, L.G.; de Moraes Porto, I.C.; Lima, E.M.T.; Basílio-Júnior, I.D.; Grillo, L.A.M.; Dornelas, C.B.; da Silva Fonseca, E.J.; et al. Polymeric nanoparticles of Brazilian red propolis extract: Preparation, characterization, antioxidant and Leishmanicidal activity. Nanoscale Res. Lett. 2016, 11, 301. [Google Scholar] [CrossRef]
- Rivas, C.J.M.; Tarhini, M.; Badri, W.; Miladi, K.; Greige-Gerges, H.; Nazari, Q.A.; Rodríguez, S.A.G.; Román, R.A.; Fessi, H.; Elaissari, A. Nanoprecipitation process: From encapsulation to drug delivery. Int. J. Pharm. 2017, 532, 66–81. [Google Scholar] [CrossRef] [PubMed]
- Martínez-Muñoz, O.I.; Mora-Huertas, C.E. Nanoprecipitation technology to prepare carrier systems of interest in pharmaceutics: An overview of patenting. Int. J. Pharm. 2022, 614, 121440. [Google Scholar] [CrossRef]
- Müller, R.H.; Gohla, S.; Keck, C.M. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharm. Biopharm. 2011, 78, 1–9. [Google Scholar] [CrossRef]
- Miladi, K.; Sfar, S.; Fessi, H.; Elaissari, A. Nanoprecipitation process: From particle preparation to in vivo applications. In Polymer Nanoparticles for Nanomedicines: A Guide for Their Design, Preparation and Development; Vauthier, C., Ponchel, G., Eds.; Springer: Cham, Switzerland, 2016; pp. 17–53. [Google Scholar] [CrossRef]
- Paliwal, R.; Babu, R.J.; Palakurthi, S. Nanomedicine scale-up technologies: Feasibilities and challenges. AAPS PharmSciTech 2014, 15, 1527–1534. [Google Scholar] [CrossRef] [PubMed]
- Wacker, M.; Zensi, A.; Kufleitner, J.; Ruff, A.; Schütz, J.; Stockburger, T.; Marstaller, T.; Vogel, V. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation. Int. J. Pharm. 2011, 414, 225–232. [Google Scholar] [CrossRef]
- Reverchon, E. Supercritical-assisted atomization to produce micro-and/or nanoparticles of controlled size and distribution. Ind. Eng. Chem. Res. 2022, 41, 2405–2411. [Google Scholar] [CrossRef]
- Reverchon, E.; Della Porta, G. Micronization of antibiotics by supercritical assisted atomization. J. Supercrit. Fluids 2003, 26, 243–252. [Google Scholar] [CrossRef]
- Di Capua, A.; Adami, R.; Reverchon, E. Production of luteolin/biopolymer microspheres by supercritical assisted atomization. Ind. Eng. Chem. Res. 2017, 56, 4334–4340. [Google Scholar] [CrossRef]
- Adami, R.; Di Capua, A.; Reverchon, E. Supercritical Assisted Atomization for the production of curcumin-biopolymer microspheres. Powder Technol. 2017, 305, 455–461. [Google Scholar] [CrossRef]
- Kanaze, F.I.; Kokkalou, E.; Niopas, I.; Barmpalexis, P.; Georgarakis, E.; Bikiaris, D. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions. Drug Dev. Ind. Pharm. 2010, 36, 292–301. [Google Scholar] [CrossRef]
- Di Capua, A.; Bejarano, A.; Adami, R.; Reverchon, E. Preparation and characterization of Chilean propolis coprecipitates using Supercritical Assisted Atomization. Chem. Eng. Res. Des. 2018, 136, 776–785. [Google Scholar] [CrossRef]
- Koch, N.; Jennotte, O.; Gasparrini, Y.; Vandenbroucke, F.; Lechanteur, A.; Evrard, B. Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers. Int. J. Pharm. 2020, 589, 119812. [Google Scholar] [CrossRef] [PubMed]
- De Marco, I.; Franco, P. Effect of the carrier on the coprecipitation of curcumin through supercritical-assisted atomization. Chem. Eng. 2021, 5, 59. [Google Scholar] [CrossRef]
- Mottola, S.; De Marco, I. Production of inclusion complexes containing corticosteroids by SAA process. J. Supercrit. Fluids 2024, 204, 106115. [Google Scholar] [CrossRef]
- Reverchon, E.; Scognamiglio, M.; Baldino, L. Lycopene extract from tomato concentrate and its co-precipitation with PVP using hybrid supercritical processes. J. CO2 Util. 2022, 64, 102157. [Google Scholar] [CrossRef]
- Reverchon, E.; Scognamiglio, M.; Baldino, L. The nanostructure of polymer-active principle microparticles produced by supercritical CO2 assisted processing. Nanomaterials 2022, 12, 1401. [Google Scholar] [CrossRef]
- Hazekamp, A.; Peltenburg, A.; Verpoorte, R.; Giroud, C. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa L. J. Liq. Chromatogr. Relat. Technol. 2005, 28, 2361–2382. [Google Scholar] [CrossRef]
- Khalily, M.P. Improving the water solubility of cannabidiol using a peptide carrier. Turk. J. Chem. 2024, 48, 229–236. [Google Scholar] [CrossRef]
- Sorrentino, N. Production of Micro and Nanoparticles of Polymer/Cannabinoid by SAA. Master’s Thesis, Department of Industrial Engineering, University of Salerno, Fisciano, Italy, 2022. [Google Scholar]
- Andriotis, E.G.; Chachlioutaki, K.; Monou, P.K.; Bouropoulos, N.; Tzetzis, D.; Barmpalexis, P.; Chang, M.W.; Ahmad, Z.; Fatouros, D.G. Development of Water-Soluble Electrospun fibers for the oral delivery of cannabinoids. AAPS PharmSciTech 2021, 22, 1–14. [Google Scholar] [CrossRef]
Sample | CBG/PVP Mass Ratio | Microparticles’ Mean Diameters, nm | Standard Deviation, nm |
---|---|---|---|
S1 | 573 | 459 | |
S2 | 379 | 307 | |
S3 | 288 | 251 |
Sample | Total Concentration, mg/mL | Microparticles’ Mean Diameters, nm | Standard Deviation, nm |
---|---|---|---|
S1_10 | 10 | 573 | 459 |
S1_20 | 20 | 660 | 420 |
S1_30 | 30 | 771 | 371 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Baldino, L.; Sarnelli, S.; Scognamiglio, M.; Reverchon, E. Production of Biopolymeric Microparticles to Improve Cannabigerol Bioavailability. Materials 2024, 17, 4227. https://doi.org/10.3390/ma17174227
Baldino L, Sarnelli S, Scognamiglio M, Reverchon E. Production of Biopolymeric Microparticles to Improve Cannabigerol Bioavailability. Materials. 2024; 17(17):4227. https://doi.org/10.3390/ma17174227
Chicago/Turabian StyleBaldino, Lucia, Sonia Sarnelli, Mariarosa Scognamiglio, and Ernesto Reverchon. 2024. "Production of Biopolymeric Microparticles to Improve Cannabigerol Bioavailability" Materials 17, no. 17: 4227. https://doi.org/10.3390/ma17174227